Table 2 Correlation between CCDC88A expression and clinicopathological parameters

Stage^a

0.938

0

2.6

[n = 2]

0

[n = 0]

IA

3.9

[n = 3]

4.0

[n = 1]

IB

7.8

[n = 6]

8.0

[n = 2]

IIA

29.9

[n = 23]

36.0

[n = 9]

IIB

50.6

[n = 39]

44.0

[n = 11]

III

1.3

[n = 1]

4.0

[n = 1]

IV

3.9

[n = 3]

4.0

[n = 1]

Primary tumor^a

0.656

Tis

2.6

[n = 2]

0

[n = 0]

T1

6.5

[n = 5]

4.0

[n = 1]

T2

13.0

[n = 10]

20.0

[n = 5]

T3

76.6

[n = 59]

72.0

[n = 18]

T4

1.3

[n = 1]

4.0

[n = 1]

Regional lymph nodes^a

0.644

N0

44.2

[n = 34]

52.0

[n = 13]

N1

55.8

[n = 43]

48.0

[n = 12]

Distant metastasis^a

1

M0

96.1

[n = 74]

96.0

[n = 24]

M1

3.9

[n = 3]

4.0

[n = 1]

Histology^b

0.9391

PanIN

2.6

[n = 2]

0

[n = 0]

Well

29.9

[n = 23]

32.0

[n = 8]

Moderate

54.5

[n = 42]

60.0

[n = 15]

Poor

13.0

[n = 10]

8.0

[n = 2]

Venous invasion^b

0.741

v0 + v1

87

[n = 67]

84.0

[n = 21]

V2 + v3

13

[n = 10]

16.0

[n = 4]

Lymphatic invasion^b

0.789

ly0 + ly1

76.6

[n = 59]

72.0

[n = 18]

ly2 + ly3

23.4

[n = 18]

28.0

[n = 7]

Recurrence

0.133

Yes

67.5

[n = 52]

84.0

[n = 21]

No

22.5

[n = 25]

16.0

[n = 4]